Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement For Minimum Market Value Of Publicly Held Shares
Portfolio Pulse from Benzinga Newsdesk
Trinity Biotech has received a notice of non-compliance from Nasdaq regarding the minimum market value of publicly held shares required for continued listing on the Nasdaq Global Select Market. The company has a compliance period of 180 days to meet the minimum requirement, failing which it may be subject to delisting procedures.
November 28, 2023 | 9:09 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Trinity Biotech has been notified by Nasdaq of its non-compliance with the minimum market value requirement. The company has 180 days to regain compliance, otherwise, it risks being delisted from the Nasdaq Global Select Market.
Receiving a non-compliance notice is a negative signal to the market, indicating that the company is not meeting Nasdaq's listing standards. This could lead to decreased investor confidence and potential selling pressure on TRIB's shares in the short term. The risk of delisting can also affect the stock's liquidity and attractiveness to institutional investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100